Connect with us

Crypto World

Prediction Market Aggregator Stand Launches Counter-Trading Tool

Published

on

the-defiant

The new tool lets users automate bets against consistent losers — instead of trying to copy winners.

Prediction markets are everywhere. But rising participation doesn’t necessarily transform into profits for regular users.

Prediction market aggregator Stand announced today, Feb. 13, that it’s launching a tool to let users automatically take the opposite position of trades across popular platforms — namely from traders that tend to lose. Edward Ridgely, founder of Stand, said in a press release shared with The Defiant that conventional copy‑trading breaks down in prediction markets.

“Many operate multiple wallets and can easily front-run anyone copying their moves. The more interesting edge is in systematically counter-trading the consistent losers,” Ridgely explained.

Advertisement

The new feature on Stand allows counter-bets against systematically bad bettors, and also helps users avoid common pitfalls, such as blindly following traders who perform well in one market but lose their edge in others.

Destined to Lose

It’s worth noting, however, that there’s currently no rigorous research quantifying how profitable either copy‑trading or counter‑trading bots are for users in prediction markets.

What the data does show so far, however, is a clear concentration of profits among a small cohort of systematic participants, leaving the majority of retail traders on the wrong side of outcomes.

About 70 % of traders on Polymarket lose money, according to a December 2025 study by Felix Reichenbach of Technische Universität Berlin and Martin Walther of the German International University.

Advertisement
the-defiant
Fraction of traders with positive total profits over time on Polymarket. Source: SSRN

The researchers analyzed more than 124 million trades and found that only around 30% of accounts ended the period with net gains, meaning 70% of participants were on the losing side.

That gap in profitability has shaped trader behavior. Multiple automated copy‑trading bots like PolyFlash or PolydexLab allow users to mirror the positions of top wallets in real time, usually for subscription fees.

This arms-race-like dynamic has made simple copy-trading almost ineffective, given that the most successful accounts can just front‑run the crowd by reacting to profitable trades faster on-chain.

Prediction Market Mania

Prediction markets exploded in popularity in 2025, kicking off mainstream usage with the U.S. 2024 presidential election. The largest platforms, Polymarket and Kalshi, have pushed into mainstream markets with an accelerating number of high-profile media and sports partnerships with the likes of the NHL, UFC, MLS, as well as Dow Jones, X, and CNBC.

Sports, politics, culture and crypto markets are now attracting hundreds of millions of dollars, underscoring how much capital these platforms are drawing.

Advertisement

Open interest across platforms surged past $1.1 billion earlier this month, while trading volumes also broke new highs, as The Defiant reported earlier.

Stand’s own monthly DEX volumes via its prediction market terminal have been on the rise since it launched in October, reaching $16.44 million in January.

the-defiant
Monthly DEX volumes on Stand. Source: DefiLlama

Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Crypto World

Moderna (MRNA) Stock Slips Despite Beating Q4 Revenue and Earnings Estimates

Published

on

MRNA Stock Card

TLDR

  • Moderna reported Q4 revenue of $678 million, beating Wall Street estimates of $626.1 million, driven by COVID-19 vaccine sales
  • The company posted a quarterly loss of $2.11 per share, narrower than the $2.54 per share loss analysts expected
  • Moderna reiterated its 2026 revenue growth target of 10% and expects 50% of sales from U.S. markets and 50% from international
  • FDA refused to review Moderna’s flu vaccine application this week, citing trial design flaws, despite internal staff reviewers supporting the review
  • Moderna stock slipped 0.3% in premarket trading Friday despite beating earnings, after rising 36% year-to-date through Thursday

Moderna shares dipped 0.3% in premarket trading Friday even after the biotech company delivered quarterly results that topped Wall Street expectations. The mixed reaction highlights investor concerns about the company’s path forward after a rough week.

The Cambridge-based vaccine maker reported fourth-quarter revenue of $678 million. That beat analyst estimates of $626.1 million.

Full-year 2025 sales reached $1.94 billion, surpassing the $1.89 billion consensus estimate. COVID-19 vaccine sales drove the better-than-expected performance.


MRNA Stock Card
Moderna, Inc., MRNA

Moderna posted a quarterly loss of $2.11 per share. Analysts had projected a steeper loss of $2.54 per share. The latest loss was narrower than the $2.91 per share loss recorded in the same quarter last year.

CEO Stéphane Bancel said the company entered the year “with strong momentum despite the continued challenging environment in the U.S.” The company reaffirmed its expectation for 10% revenue growth in 2026 compared to 2025.

Wall Street currently expects revenue growth of about 6% for the year. Moderna forecast research and development expenses of roughly $3 billion for 2026, matching analyst estimates.

Advertisement

FDA Setback Casts Shadow

The earnings beat came days after a setback with regulators. The FDA refused Tuesday to review Moderna’s seasonal flu vaccine application.

FDA vaccine chief Vinay Prasad said the company should have compared its vaccine to standard high-dose flu shots for older adults. Moderna ran its trial using regular-dose comparisons, which the company says FDA approved 18 months ago.

Internal FDA staff reviewers had supported moving forward with the review. Prasad overruled them, according to a Wednesday report from Stat.

Moderna criticized the decision and said it was awaiting further guidance on refiling. The company has been counting on its flu vaccine and a future COVID-flu combination shot to drive future growth.

Advertisement

Looking Ahead to 2026

The company expects about 50% of 2026 sales to come from U.S. markets. International markets will account for the remaining half.

Bancel said Moderna expects to meet its 2026 targets through expansion of its next-generation COVID vaccine. Strategic partnerships in international markets will also play a role.

Shares had climbed 36% year-to-date through Thursday’s close. Positive Phase 2b trial results for an intismeran autogene vaccine used in melanoma treatment drove much of the rally.

The company continues working on newer products to offset declining COVID vaccine demand. Sales have struggled since the pandemic windfall years when demand for COVID shots collapsed.

Advertisement

Moderna’s full-year 2025 revenue of $1.94 billion came in above the $1.89 billion analyst consensus, while the company maintains its 10% revenue growth target for 2026.

Source link

Advertisement
Continue Reading

Crypto World

Crypto calm before the storm: BTC bounces, altcoins flounder

Published

on

Crypto calm before the storm: BTC bounces, altcoins flounder

Bitcoin flirted with US$60,000 last week before staging a modest recovery, leaving altcoins to nurse bruised egos and investors to wonder if they’re holding the next “dead token.” Meanwhile, AI stocks are stealing capital and attention like a toddler in a candy store. Welcome to crypto’s latest de-risking phase, where patience is as much an asset as Bitcoin itself.

Summary

  • Bitcoin dropped roughly 50% from its October 2025 high, with altcoins lagging heavily as investors rotate capital toward AI, defensive narratives, and larger, more durable crypto assets.
  • Hawkish Fed expectations, a cooling labor market, and geopolitical uncertainties are limiting liquidity and short-term risk appetite, keeping rate cuts off the table and sustaining volatility.
  • Despite the drawdown, institutional participation, stablecoin liquidity, real-world asset tokenization, and DeFi adoption continue to grow, laying the groundwork for medium-term opportunities once market sentiment shifts.

According to a Binance analysis, markets are caught between two powerful forces: a rotation of capital away from speculative crypto bets toward AI and defensive narratives, and a macro backdrop dominated by hawkish Fed expectations, potential government shutdown jitters, and global trade tensions.

The result is a market that’s temporarily favoring durability over hype, forcing smaller tokens to either prove their worth or quietly fade into obscurity. For Bitcoin, this 50% drawdown from last October’s all-time high is more of a cleansing than a collapse—and it may be laying the groundwork for the next chapter.

Advertisement

Investors are learning a lesson in selective attention. As Bitcoin consolidates around US$60,000–65,000, altcoins continue to lag, dragged down by a flood of 2025 token launches. Roughly 11.6 million of the 20.2 million new tokens released last year—many with little to no users or revenue—have already vanished from active trading.

CoinGecko and Binance report that more than half of these new entrants have endured brutal drawdowns, leaving hype-driven speculators nursing losses while projects with real fundamentals fight for visibility.

Yet the long tail isn’t completely dead. Some smaller assets have shown muted moves recently, reflecting that much of the early deleveraging has already occurred. In other words, the selling pressure is tiring—not that buyers are back in force. Meanwhile, equity markets have also repriced risk, particularly in software, where AI-driven disruption has outperformed Bitcoin in relative terms, creating a liquidity tug-of-war between crypto and tech.

Advertisement

The irony?

The same AI narrative driving stocks higher is one of the most compelling use cases for blockchain: machine-speed payments, programmable money, and cross-border settlements. Short-term, AI is siphoning attention. Medium-term, it may become crypto’s most loyal customer.

Macro factors remain the primary driver. January’s U.S. jobs report showed 130,000 new positions and unemployment at 4.3%, superficially encouraging but revealing a weak underlying trend once benchmark revisions for 2025 are considered. The Fed, under incoming chair Kevin Warsh, is unlikely to loosen policy soon, keeping liquidity tight—a headwind for Bitcoin, historically sensitive to shifts in global cash flows.

Despite the drawdown, structural tailwinds persist. Spot BTC ETF assets under management have only modestly declined, hinting at a sticky investor base focused on strategic allocation rather than momentum chasing. Digital asset treasuries, by contrast, are less aggressive buyers, suggesting balance-sheet strategies are becoming more conservative. Stablecoins have remained plentiful, maintaining the plumbing for future on-chain transactions.

Real-world assets (RWAs) and tokenization have become the new safe harbors. Tokenized treasuries, commodities, and yield-focused structures now total nearly US$25 billion, with tokenized gold surging over 50% since the start of 2026. Tether Gold (XAUT) recently exceeded US$2.6 billion in market cap, a reminder that even in a risk-off phase, crypto can find its bedrock.

Advertisement

DeFi continues to converge with traditional finance. BlackRock’s move to make shares of its tokenized U.S. Treasury fund BUIDL tradable via UniswapX, along with its purchase of UNI governance tokens, signals institutional confidence in decentralized infrastructure. Liquidity exists; it’s just selective, waiting for the right catalyst.

Looking ahead, markets remain poised for volatility while macro signals clarify. Bitcoin’s realized price—roughly US$55,000—marks a psychological pivot point, where holders near breakeven can amplify swings. Yet the difference from prior cycles is clear: this is a deeper, structurally stronger market. Stablecoin rails are solid, RWAs are scaling, DeFi adoption continues, and institutions are quietly embedding digital assets into portfolios.

History suggests that when prices compress but fundamentals advance, conviction builds beneath the surface. Once risk reprices, the winners of this patient phase—projects with real utility, institutional backing, or durable narratives—are often the ones to lead the next leg up. In crypto, as in comedy, timing is everything: the punchline comes after the pause.

Advertisement

Source link

Continue Reading

Crypto World

Is Bitcoin Trading Like a Tech Stock?

Published

on

Is Bitcoin Trading Like a Tech Stock?

Bitcoin (BTC) was once pitched as digital gold — a hedge against monetary instability and market turmoil. But recent price action tells a different story.

As institutional participation has grown, particularly through exchange-traded funds and other traditional vehicles, Bitcoin has increasingly traded in lockstep with risk assets. The latest downturn in software stocks, fueled by renewed uncertainty around AI’s impact on the sector, has been mirrored in crypto markets, raising fresh questions about Bitcoin’s evolving identity.

That changing dynamic sets the tone for this week’s Crypto Biz. New research from Grayscale examines Bitcoin’s growing correlation with growth equities, while one Ether (ETH) treasury company is doubling down despite multibillion-dollar paper losses. Elsewhere, BlackRock is expanding its tokenization push through a Uniswap integration, and Polymarket is taking its fight over state regulation to federal court.

Grayscale: Bitcoin is trading like a growth asset, not digital gold

New research from Grayscale suggests that Bitcoin’s store-of-value narrative has recently taken a back seat, with the digital asset behaving more like a growth stock.

Advertisement

In the report, author Zach Pandl said that while Grayscale continues to view Bitcoin as a long-term store of value due to its fixed supply and independence from central banks, its short-term trading patterns resemble those of high-growth equities.

The analysis found a strong correlation between Bitcoin and software stocks over the past two years. That relationship has become more apparent as software companies face renewed selling pressure amid concerns that artificial intelligence could disrupt parts of the industry.

Against that backdrop, Bitcoin’s recent pullback appears less surprising, as its price has closely tracked the software sector’s movements.

Bitcoin’s recent price performance tracks closely with software stocks. Source: Grayscale

BitMine adds 40,613 ETH during market sell-off

Ether treasury company BitMine Immersion Technologies added 40,613 ETH to its holdings during the recent market sell-off, reinforcing its long-term bet on Ether even as prices plunge and paper losses reach billions of dollars. 

The purchase raised BitMine’s total Ether stash to more than 4.326 million ETH, worth about $8.8 billion at current levels. According to DropsTab data, the company is now sitting on around $8.1 billion in unrealized losses on its ETH position, reflecting a significant gap between its cost basis and today’s market price.

Advertisement

Despite investor criticism and pressure on its stock price, which has fallen sharply over recent months, BitMine chairman Tom Lee said the company’s strategy is designed to track Ether’s long-term trajectory and benefit from future recoveries. The company’s broader crypto and cash portfolio is valued at roughly $10 billion.

BitMine’s paper losses now exceed $8.1 billion. Source: DropStab

BlackRock buys UNI, brings BUIDL to Uniswap

BlackRock is deepening its push into decentralized finance by listing its tokenized money market fund on Uniswap, a significant step for institutional DeFi adoption.

The asset manager’s USD Institutional Digital Liquidity Fund (BUIDL) is now available on the decentralized exchange, giving whitelisted institutional investors the ability to trade the tokenized Treasury product onchain. As part of the move, BlackRock is also purchasing Uniswap’s governance token, UNI.

BUIDL is the largest tokenized money market fund, with more than $2.1 billion in assets. The fund is issued across multiple blockchains, including Ethereum, Solana and Avalanche. In December, it surpassed $100 million in cumulative distributions generated from its US Treasury holdings.

BlackRock’s BUIDL has more than $2.1 billion in assets. Source: RWA.xyz

Polymarket sues Massachusetts over state regulation of prediction markets

Decentralized prediction market Polymarket has filed a federal lawsuit against the state of Massachusetts, challenging state authorities’ efforts to restrict or shut down its event-based trading products. 

Polymarket’s chief legal officer, Neal Kumar, confirmed the filing on Monday, saying unresolved legal questions around jurisdiction should be settled at the federal level rather than through state enforcement. The lawsuit is preemptive, aimed at blocking any action by Massachusetts Attorney General Andrea Campbell that Polymarket contends would unlawfully interfere with federally regulated markets.

Advertisement

The company argues that the Commodity Futures Trading Commission (CFTC), not individual states, has exclusive authority over event contracts like those offered on its platform, and that state actions risk fragmenting national markets.

Source: Neal Kumar

Crypto Biz is your weekly pulse on the business behind blockchain and crypto, delivered directly to your inbox every Thursday.